Beyond lung function in COPD management: effectiveness of LABA/LAMA combination therapy on patient-centred outcomes
Open Access
- 5 January 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Primary Care Respiratory Journal
- Vol. 21 (1), 101-108
- https://doi.org/10.4104/pcrj.2011.00102
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Cardiovascular Safety of QVA149, a Combination of Indacaterol and NVA237, in COPD PatientsCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2010
- QVA149 demonstrates superior bronchodilation compared with indacaterol or placebo in patients with chronic obstructive pulmonary diseaseThorax, 2010
- Association of PHF11 polymorphisms with asthma and allergyThorax, 2010
- Development and first validation of the COPD Assessment TestEuropean Respiratory Journal, 2009
- Efficacy and Safety of Nebulized Formoterol as Add-on Therapy in COPD Patients Receiving Maintenance Tiotropium BromideDrugs, 2009
- Formoterol and Tiotropium Compared With Tiotropium Alone for Treatment of COPDCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2009
- Predictors of COPD symptoms: does the sex of the patient matter?European Respiratory Journal, 2006
- Lung function decline and outcomes in an elderly populationThorax, 2006
- Dynamic Hyperinflation: Is It Worth Measuring?Proceedings of the American Thoracic Society, 2006
- Methodological issues in evaluating measures of health as outcomes for COPDEuropean Respiratory Journal, 2003